# The Multicentre Selective Lymphadenectomy Trial - 3

> **NCT07049276** · NA · RECRUITING · sponsor: **Melanoma Institute Australia** · enrollment: 1500 (estimated)

## Conditions studied

- Cutaneous Melanoma, Stage III

## Interventions

- **PROCEDURE:** Index lymph node resection
- **PROCEDURE:** Therapeutic lymph node dissection

## Key facts

- **NCT ID:** NCT07049276
- **Lead sponsor:** Melanoma Institute Australia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2030-08
- **Final completion:** 2040-08
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07049276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07049276, "The Multicentre Selective Lymphadenectomy Trial - 3". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07049276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*